Enhancing the immunotherapeutic potential of mycobacteria by transfection with tumour necrosis factor-α

Immunology

Volumn 96, Issue 1, 1999, Pages 114-121

  Haley, J L ^a   Young, D G ^a   Alexandroff, A ^a   James, K ^a   Jackson, A M ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; RANTES; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOTHERAPY; MYCOBACTERIUM; MYCOBACTERIUM SMEGMATIS; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL CULTURE;

CLONING, MOLECULAR; CYTOKINES; CYTOTOXICITY TESTS, IMMUNOLOGIC; ESCHERICHIA COLI; FLOW CYTOMETRY; GENETIC VECTORS; HUMANS; IMMUNOTHERAPY, ADOPTIVE; MYCOBACTERIUM SMEGMATIS; NEOPLASMS; RECOMBINANT PROTEINS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032948779     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1999.00667.x     Document Type: Article

References (40)

1. 1. MATHÉ G., AMIEL J. & SCHWAZENBERG L. (1969) Acute immunotherapy for acute lymphoblastoid leukemia. Lancet I, 697.
2. 2. MORALES A. & EDINGER D. (1976) Bacillus Calmette-Guérin in the treatment of adenocarcinoma of the kidney. J Urol 115, 377.
3. 3. GRANT R., COCHRAN A.J., HOYLE D. et al. (1974) Results of administering BCG to patients with melanoma. Lancet I, 1096.
4. 4. LAMM D.L. (1992) Carcinoma In Situ. Urol Clin North Am 19, 499.
5. 5. RATLIFF T.L., KAVOUSSI L.R. & CATALONA W.J. (1988) Role of fibronectin in intravesical BCG therapy for superficial bladder cancer. J Urol 139, 410.
6. 6. PRESCOTT S., JAMES K. & HARGREAVE T. (1992) Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall. J Urol 147, 1636.
7. 7. RATLIFF T.L., HAAF E.O. & CATALONA W.J. (1986) Interleukin-2 production during intravesical bacillus Calmette-Guérin therapy for bladder cancer. Clin Immunol Immunopathol 40, 375.
8. 8. FLEISHMANN J.D., TOOSSI Z., ELLNER J.J. et al. (1989) Urinary interleukins in patients receiving intravesical bacillus Calmette-Guérin therapy for superficial bladder cancer. Cancer 64, 1447.
9. 9. DE BOER E.C., DE JONG W.H., STEERENBERG P.A. et al. (1992) Induction of interleukin-1 (IL-1), IL-2, IL-6 and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancer. Cancer Immunol Immunother 34, 306.
10. 10. JACKSON A.M., HAWKYARD S.J., PRESCOTT S. et al. (1993) The immunomodulatory effects of urine from patients with superficial bladder cancer receiving intravesical Evans BCG therapy. Cancer Immunol Immunother 36, 25.
11. 11. JACKSON A.M., ALEXANDROFF A.B., KELLY R.W. et al. (1995) Changes in urinary cytokines and soluble intercellular adhesion molecule-1 (ICAM-1) in bladder cancer patients after Bacillus Calmette-Guérin (BCG) immunotherapy. Clin Exp Immunol 99, 369.
12. 12. ALEXANDROFF A.B., JACKSON A.M., SKIBINSKA A. & JAMES K. (1996) Production of IL-5, a classical T (H) 2 cytokine, following BCG immunotherapy of bladder cancer. Int J Oncol 9, 179.
13. 13. JACKSON A.M., ALEXANDROFF A.B. & JAMES K. (1995) BCG directly influences expression of ICAM-1. EFIS meeting (Barcelona) abs W23.18.
14. 14. HAYASHI O., AKASHI M., FUJIME M. et al. (1994) Detection of IL-1 activity in bladder cancer cell lines. J Urol 151, 750.
15. 15. ESUVARANTHAN K., ALEXANDROFF A.B., MCINTYRE M. et al. (1995) Interleukin-6 production by bladder tumours is upregulated by BCG immunotherapy. J Urol 154, 572.
16. 16. PRESCOTT S., JAMES K., BUSUTILL A. et al. (1989) HLA-DR expression by high grade superficial bladder cancer treated with BCG. Br J Urol 63, 264.
17. 17. JACKSON A.M., ALEXANDROFF A.B., MCINTYRE M. et al. (1994) BCG immunotherapy induces ICAM-I expression on bladder tumours. J Clin Pathol 47, 309.
18. 18. JACKSON A.M., ALEXANDROFF A.B., PRESCOTT S. et al. (1992) Role of adhesion molecules in lymphokine activated killer cell killing of bladder cancer cells: further evidence for a third ligand for leucocyte function associated antigen-I. Immunology 76, 286.
19. 19. JACKSON A.M., ALEXANDROFF A.B., PRESCOTT S. el al. (1992) Expression of adhesion molecules by bladder cancer cells: Modulation by interferon-gamma and tumour necrosis factor-alpha. J Urol 148, 1583.
20. 20. CAMPBELL S.C., TANABE K., ALEXANDER J.P. et al. (1994) Intercellular adhesion molecule-1 expression by bladder cancer cells: functional effects. J Urol 151, 1385.
21. 21. LATTIME E.C., GOMELLA L.G. & MCCUE P.A. (1992) Murine bladder carcinoma cells present antigen to BCG-specific CD4+ T-cells. Cancer Res 52, 4286.
22. 22. O'DONNELL M.A., ALDOVINI A., DUDA R.B. et al. (1994) Recombinant Mycobacterium bovis BCG secreting functional interleukin-2 enhances gamma interferon production by splenocytes. Infect Immun 62, 2508.
23. 23. KONG D. & KUNIMOTO D.Y. (1995) Secretion of human interleukin-2 by recombinant Mycobacterium bovis BCG. Infect Immun 63, 799.
24. 24. MURRAY P.J., ALDOVINI A. & YOUNG R.A. (1996) Manipulation and potentiation of antimycobacterial immunity using recombinant bacille Calmette-Guérin strains that secrete cytokines. Proc Natl Acad Sci USA 93, 934.
25. 25. SUGARMAN B.J., AGGARWAL B.B., HASS P.E. et al. (1985) Recombinant human tumour necrosis factor α: effects on proliferation of normal and transformed cells in vitro. Science 230, 943.
26. 26. HAWKYARD S.J., JACKSON A.M., PRESCOTT S. et al. (1993) The effect of recombinant cytokines on bladder cancer cells in vitro. J Urol 150, 514.
27. 27. JACKSON A.M., HAWKYARD S.J., PRESCOTT S. et al. (1992) An investigation of factors influencing the in vitro induction of LAK activity against a variety of human bladder cancer cell lines. J Urol 147, 207.
28. 28. BEUTLER B. & CERAMI A. (1989) The biology of cachectin, TNF-α primary mediator of the host response. Annu Rev Immunol 7, 625.
29. 29. DEMARCO R., ENSOR J. & HASDAY J. (1992) Tumour-stimulated release of tumour necrosis factor-alpha by human monocyte derived macrophages. Cellular Immunol 140, 304.
30. 30. KREMER L., BAULARD A., ESTAQUIER J. et al. (1995) Green fluorescent protein as a new expression marker in mycobacteria. Mol Microbiol 17, 913.
31. 31. HOGAN M.M. & VOGEL S.N. (1991) Measurement of tumour necrosis factor α and β. In: Current Protocols in Immunology, Vol 1, (eds. COLIGAN J.E., KRUISBEEK A.M., MARGULIES D.H. et al.) Unit 6.10. Wiley and Sons, New York.
32. 32. JACKSON A.M., ALEXANDROFF A.B., FLEMING D. et al. (1994) Bacillus Calmette-Guérin (BCG) organisms directly alter the growth of bladder tumour cells. Int J Oncol 5, 697.
33. 33. ALEXANDROFF A.B., JACKSON A.M., ESUVARANATHAN K. et al. (1994) Autocrine regulation of ICAM-1 expression on bladder cancer cell lines: evidence for the role of IL-1α. Immunol Lett 40, 117.
34. 34. AGGARWAL B.B., KOHR W.J., HASS P.E. et al. (1985) Human tumour necrosis factor: Production, purification and characterisation. Biol Chem 260, 2345.
35. 35. NETA R., SAYER T.J. & OPPENHEIM J.J. (1992) Relationship of TNF to interleukins. Immunology Series 56, 499.
36. 36. ARTEAGA C.L., CARTY-DUGGER T., MOSES H.L. et al. (1993) TGFβ1 can induce oestrogen-independent tumourigenicity of human breast cancer cells in athymic mice. Cell Growth Diff 4, 193.
37. 37. CHANG H.L., GILLETT N., FIGARI I. el al. (1993) Increased TGFβ expression inhibits cell proliferation in vitro, yet increases tumourigenicity and tumour growth of Meth A sarcoma cells. Cancer Res 53, 4391.
38. 38. BÖHLE A., THANHÄUSER A., ULMER A.J. et al. (1993) Dissecting the immunobiological effects of bacillus Calmette-Guérin (BCG) in vitro: evidence of a distinct BCG-activated killer (BAK) cell phenomenon. Urol 150, 1932.
39. 39. THANHÄUSER A., BÖHLE A., SCHNEIDER B. et al. (1995) The induction of bacillus Calmette-Guérin-activated killer cells requires the presence of monocytes and T-helper type-1 cells. Cancer Immunol Immunother 40, 103.
40. 40. THANHÄUSER A., BÖHLE A., FLAD H.-D. et al. (1993) Induction of bacillus Calmette-Guérin-activated killer cells from human peripheral blood mononuclear cells against human bladder carcinoma cell lines in vitro. Cancer Immunol Immunother 37, 105.